ApprovalTrail

Drug · DIN 02029529

SOFLAX

GELCAPS

No: no longer authorized

The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.

Status Cancelled Post Market since July 4, 2022; first marketed April 16, 1998.
Drug Identification Number (DIN)
02029529
Company (DIN owner)
Pharmascience Inc.Montreal, Quebec, Canada
Schedule
Non-prescription drugs
Dosage form
Capsule
Route
Oral
Therapeutic class (ATC)
Docusate sodium A06AA02
Class
Human
Record last updated
March 22, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DOCUSATE SODIUM200 MG